235
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Acute effects of snus in never-tobacco users: a pilot study

, MS, , BA, , MD & , PhD
Pages 113-119 | Received 26 May 2016, Accepted 10 Nov 2016, Published online: 08 Dec 2016

References

  • Rutqvist LE, Curvall M, Hassler T, Ringberger T, Wahlberg I. Swedish snus and the GothiaTek standard. Harm Reduct J 2011;8:11.
  • Hatsukami DK, Joseph AM, LeSage M,..., Hecht SS. Developing the science base for reducing tobacco harm. Nicotine Tobacco Res 2007;9:537–553.
  • Andersson G, Axell T. Clinical appearance of lesions associated with the use of loose and portion-bag packed Swedish moist snuff: a comparative study. J Oral Pathol Med 1989;1:2–7.
  • Luo J, Ye W, Zendehdel K,..., Nyren O. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 2007;369:16–22.
  • Lee PN. The effect on health of switching from cigarettes to snus – a review. Regul Toxicol Pharmacol 2013;66:1–5.
  • Foulds J, Ramstrom L, Burke M, Fagerstrom K. Effects of smokeless tobacco (snus) on smoking and public health in Sweden. Tobacco Control 2003;12:349–350.
  • Soneji S, Sargent JD, Tanski SE, Primack BA. Associations between initial water pipe tobacco smoking and snus use and subsequent cigarette smoking: results from a longitudinal study of US adolescents and young adults. JAMA Pediatr 2015;169:129–136.
  • Connolly GN. The marketing of nicotine addiction by one oral snuff manufacturer. Tobacco Control 1995;5:73–79.
  • Henningfield JE, Rose CA, Zeller M. Tobacco industry litigation position on addiction: continued dependence on past views. Tobacco Control 2006;15:iv27–iv36.
  • Choi K, Fabian L, Mottey N, Corbett A, Forster J. Young adults’ favorable perceptions of snus, dissolvable tobacco products, and electronic cigarettes: Findings from a focus group study. Am J Public Health 2012;102:2088–2093.
  • Oliver AJ, Jensen JA, Vogel RI, Anderson AJ, Hatsukami DK. Flavored and nonflavored smokeless tobacco products: rate, pattern of use, and effects. Nicotine Tobacco Res 2013;15:88–92.
  • Henningfield JE, Radzius A, Cone EJ. Estimation of available nicotine content of six smokeless tobacco products. Tobacco Control 1995;4:57–61.
  • Carpenter CM, Connolly GN, Ayo-Yusuf OA, Wayne GF. Developing smokeless tobacco products for smokers: an examination of tobacco industry documents. Tobacco Control 2009;18:54–59.
  • Liu ST, Nemeth JM, Klein EG, Ferketich AK, Kwan M, Wewers ME. Adolescent and adult perceptions of traditional and novel smokeless tobacco products and packaging in rural Ohio. Tobacco Control 2014;23:209–214.
  • Harris AC, Tally L, Schmidt CE,..., LeSage MG. Animal models to assess the abuse liability of tobacco products: Effects of smokeless tobacco extracts on intracranial self-stimulation. Drug Alcohol Depend 2015;147:60–67.
  • Cobb CO, Blank MD, Morlett A,..., Eissenberg T. Comparison of puff topography, toxicant exposure, and subjective effects in low- and high-frequency waterpipe users: A double-blind, placebo-control study. Nicotine Tobacco Res 2015;17:667–674.
  • Huynh H, Feldt LS. (1976). Estimation of the box correction for degrees of freedom from sample data in randomized block and split-plot designs. J Education Stat 2015;1:69–82.
  • Heishman SJ, Henningfield JE. Tolerance to repeated nicotine administration on performance, subjective, and physiological responses in nonsmokers. Psychopharmacol 2000;152:321–333.
  • Heishman SJ, Snyder FR, Henningfield JE. Performance, subjective, and physiological effects of nicotine in non-smokers. Drug Alcohol Depend 1993;34:11–18.
  • Fagerstrom K, Eissenberg T. Dependence on tobacco and nicotine products: A case for product-specific assessment. Nicotine Tobacco Res 2012;14:1382–1390.
  • Cobb CO, Weaver MF, Eissenberg T. Evaluating the acute effects of oral, non-combustible potential reduced exposure products marketed to smokers. Tobacco Control 2010;19:367–373.
  • Lunell E, Curvall M. Nicotine delivery and subjective effects of Swedish portion snus compared with 4 mg nicotine polacrilex chewing gum. Nicotine Tobacco Res 2011;13:573–578.
  • Lunell E, Lunell M. Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: A crossover study. Nicotine Tobacco Res 2005;7:397–403.
  • Gray JN, Breland AB, Weaver M, Eissenberg T. Potential reduced exposure products (PREPs) for smokeless tobacco users: clinical evaluation methodology. Nicotine Tobacco Res 2008;10:1441–1448.
  • Jolma CD, Samson RA, Klewer SE, Donnerstein RL, Goldberg SJ. Acute cardiac effects of nicotine in healthy young adults. Echocardiography 2002;19:443–448.
  • Martin JS, Beck DT, Gurovich AN, Braith RW. The acute effects of smokeless tobacco on central aortic blood pressure and wave reflection characteristics. Experimental Biology Med 2010;235:1263–1268.
  • Ramakrishnan S, Thangjam R, Roy A,..., Bhargava B. Acute effects of tobacco chewing on the systemic, pulmonary, and coronary circulation. Am J Cardiovasc Drugs 2011;11:109–114.
  • Benowitz NL, Porchet H, Sheiner L, Jacob P. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin Pharmacol Ther. 1988;44:23–28.
  • Duke AN, Johnson MW, Reissig CJ, Griffiths RR. Nicotine reinforcement in never-smokers. Psychopharmacol 2015;232:4243–4252.
  • Falco AM, Bevins RA. Individual differences in the behavioral effects of nicotine: A review of the preclinical animal literature. Pharmacol Biochem Behav 2015;138:80–90.
  • Perkins KA. (2009). Discriminative stimulus effects of nicotine in humans. Handbook Exp Pharmacol 192:369–400.
  • Ambrose BK, Day HR, Rostron B,…, Villanti AC. Flavored tobacco product use among US youth aged 12–17 years, 2013–2014. J Am Med Assoc 2015;314:1871–1873.
  • U.S. Smokeless Tobacco Company, David Weiss Associates. (1984). The ‘Graduation Theory’. Bates No. USSTC1945141-USSTC1945142. Retrieved from http://legacy.library.ucsf.edu/tid/lfc46b00.
  • Stepanov I, Jensen J, Hatsukami D, Hecht SS. New and traditional smokeless tobacco: Comparison of toxicant and carcinogen levels. Nicotine Tobacco Res 2008;10:1773–1782.
  • Villanti AC, Richardson A, Vallone DM, Rather JM. Flavored tobacco product use among U.S. young adults. Am J Preventive Med 2013;44:388–391.
  • Hatsukami DK, Jensen J, Anderson A, …, Severson H. Oral tobacco products: Preference and effects among smokers. Drug Alcohol Depend 2011;118:230–236.
  • Hatsukami DK, Zhang Y, O’Connor RJ, Severson HH. Subject responses to oral tobacco products: Scale validation. Nicotine Tobacco Res 2013;15:1259–1264.
  • Biener L, Roman AM, McInerney SA, …, Romito L. Snus use and rejection in the USA. Tobacco Control. Published online; 2014.
  • Choi K, Forster J. Awareness, perceptions and use of snus among young adults from the upper Midwest region of the USA. Tobacco Control 2013;22:412–417.
  • Rodu B, Plurphanswat N, Hughes JR, Fagerstrom K. Associations of proposed relative-risk warning labels for snus with perceptions and behavioral intentions among tobacco users and nonusers. Nicotine Tobacco Res Published online; 2015.
  • Taylor N, Choi K, Forster J. Snus use and smoking behaviors: preliminary findings from a prospective cohort study among US Midwest young adults. Am J Public Health 2015;105:583–685.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.